TCTMD’s Top 10 Most Popular Stories for June 2020
COVID-19’s unusual manifestations, risk factors, and possible treatments dominate the top stories on TCTMD this month.
COVID-19’s unusual manifestations, risk factors, and possible treatments were key topics among the top stories on TCTMD this month, as were stories relating to the high-profile retractions of two papers looking at hydroxychloroquine and ACE inhibitors/ARBs. Just two stories made the list for June that had nothing to do with the novel coronavirus: one reported the results of a reanalysis of the EXCEL trial, and the other was on the FDA’s decision to extend the indication for ticagrelor.
A BMJ editorial notes obesity is a modifiable risk factor for COVID-19, calling for reformulation of processed foods and a ban on ads.
We’re curating a list of COVID-19 research and other useful content, and updating it daily.
A group of scientists is asking for the numbers to be made public and externally validated. A Lancet study investigator responds.
Dexamethasone is “inexpensive, on the shelf, and can be used immediately to save lives,” says a RECOVERY researcher.
The company that owns the data set wouldn’t surrender it in full, throwing the veracity of the studies’ findings into question.
The risk is small, but study investigators emphasize the need for potent antiplatelet therapies in high-risk patients with COVID-19.
Today’s approval is based on THEMIS, the sponsor said. That will surprise those who recall the trial’s unfavorable risk-benefit data.
Physician burnout was already a concern, but now with COVID-19, experts stress the need to address the well-being of staff.
James Brophy criticizes investigators’ view of the study, but the trial’s PI fires back by citing analytical errors and omissions.
The data confirm earlier reports and show that these patients are at an increased risk of dying in the hospital.
* * *
In the wake of global protests and demonstrations demanding an end to racial inequality and police violence against people of color, TCTMD invited Keith C. Ferdinand, MD (Tulane Heart and Vascular Institute, New Orleans, LA), to contribute to our Off Script blog series.
The devaluation of black life during times of catastrophe has yet to be resolved. Now, more than ever, that should change.
All of TCTMD’s COVID-19 coverage—news, videos, and podcasts—can be found on our COVID-19 Hub.